The Joe Rogan Experience (JRE) #2060 – Gary Brecka

Joe Rogan Gary Brecka Summary: How Gary Brecka Fixed Dana White's Health

High blood pressure, also known as hypertension, is a common ailment that affects a large percentage of the population. It is often referred to as the "silent killer" because it can go unnoticed for years, causing damage to the body without any noticeable symptoms. In fact, 85% of all high blood pressure diagnoses are of unknown origin.

Understanding the underlying causes of high blood pressure is crucial in preventing and treating the condition. One factor that has been linked to hypertension is the impairment of methylation pathways, which is responsible for refining raw materials in the body into a usable form. This impairment can lead to deficiencies and ultimately result in various diseases, including high blood pressure. In this article, we will explore the role of methylation pathways in genetically inherited diseases, the link between homocysteine and hypertension, and medical interventions for hypertension.

JRE 2060: Key Takeaways

• High blood pressure is often referred to as the "silent killer" because it can go unnoticed for years without any noticeable symptoms.
• Impairment of methylation pathways can lead to deficiencies and ultimately result in various diseases, including high blood pressure.
• Understanding the underlying causes of high blood pressure is crucial in preventing and treating the condition.

The Joe Rogan Experience (JRE) #2060: Joe Rogan & Gary Brecka

Dana White, the President of the Ultimate Fighting Championship (UFC), had a life-changing experience after taking a genetic test that looks at genetic methylation pathways. He was referred to the test by a mutual friend named Carrie Kasm, who had a similar life-changing experience with the test after struggling with Lyme disease and chronic viral infection.

The test helped identify a deficiency in Dana's ability to refine a raw material, which caused a deficiency and led to his high blood pressure. Specifically, Dana had one of the highest levels of homocysteine that the clinical team had ever seen. Homocysteine is an amino acid in the bloodstream that, when impaired, causes hyperhomocysteinemia, which is linked to hypertension.

Despite being on hypertensive medication, Dana's blood pressure was still consistently high at 160/110. The clinical team took his blood pressure two to three times a day, seven days a week, and it was still elevated. The team tried beta blockers, calcium channel blockers, ACE inhibitors, and diuretics, but none of them worked.

Through the genetic test, Dana was able to identify the gene mutation specifically called MTRR, which codes for the enzymes that break down homocysteine and turn it into a harmless amino acid called methionine. Dana's inability to make this conversion was driving his blood pressure up without anything being wrong with his heart.

Overall, the Jogan Experience highlights the importance of genetic testing in identifying underlying health issues that may not be apparent through traditional diagnostic tests. By identifying deficiencies and gene mutations, individuals can take targeted actions to improve their health and prevent future health issues.

Gary Brecka: The Role of Methylation Pathways

Methylation pathways are responsible for the conversion of raw materials in the human body into usable forms. Without proper methylation, deficiencies can occur, leading to common ailments such as hypertension.

Genetic testing can identify mutations in genes that govern methylation pathways, such as the MTR and MTRR genes. Impairment in these genes can lead to an inability to break down homocysteine, an amino acid found in the bloodstream. High levels of homocysteine can cause hyperhomocysteinemia, which can lead to vascular narrowing and hypertension.

In the case of Dana White, a mutual friend introduced him to a genetic test that revealed impairments in his methylation pathways. Specifically, White had one of the highest levels of homocysteine that the clinical team had ever seen. Despite being on blood pressure medication, his hypertension remained consistently high.

Understanding the role of methylation pathways and identifying impairments through genetic testing can help individuals make necessary lifestyle changes and receive targeted treatments to improve their health.

Understanding Genetically Inherited Diseases: Gary Brecka on Joe Rogan

Genetically inherited diseases are often misunderstood as being directly passed down from generation to generation. However, what is actually passed down is the inability to refine raw materials, which leads to deficiencies and diseases. This deficiency is caused by impaired methylation pathways, which are governed by several genes.

Methylation is a process that converts raw materials in the body into a usable form. Without this conversion, the body experiences a deficiency, which can lead to common ailments such as hypertension. Homocysteine, an amino acid found in the bloodstream, has been linked to hypertension. If the body is unable to break down homocysteine and convert it into a harmless amino acid called methionine, hyperhomocysteinemia can occur, leading to inflammation and narrowing of the blood vessels, which can cause high blood pressure.

High blood pressure is often referred to as the silent killer, as it is a primary symptom of sudden death. It is essential to identify the underlying cause of high blood pressure to properly treat it. In some cases, a gene mutation, specifically MTR or MTRR, can impair the conversion of homocysteine, leading to hypertension.

Treatment for hypertension includes medication such as beta-blockers, calcium channel blockers, ACE inhibitors, and diuretics. However, these medications may not be effective if the underlying cause of hypertension is not identified.

In summary, genetically inherited diseases are caused by deficiencies resulting from impaired methylation pathways. High blood pressure is a common ailment caused by hyperhomocysteinemia, which can be caused by a gene mutation. Proper identification of the underlying cause of hypertension is crucial for effective treatment.

The Link Between Homocysteine and Hypertension

Homocysteine, an amino acid found in the bloodstream, has been linked to hypertension, or high blood pressure. While everyone has homocysteine in their blood, if there is an impaired ability to break it down and convert it into a harmless amino acid called methionine, homocysteine levels rise and cause hyperhomocysteinemia. High levels of homocysteine in the blood can become one of the more inflammatory compounds in the human body, irritating and reducing the elasticity of the artery, causing it to constrict.

This narrowing of the blood vessels can drive pressure up, leading to hypertension. In fact, 85% of all hypertensive diagnoses are of unknown origin, or idiopathic. However, high levels of homocysteine in the blood can be a contributing factor to hypertension.

Dana White, the president of the Ultimate Fighting Championship (UFC), had one of the highest levels of homocysteine that a clinical team had ever seen. He was diagnosed with hypertension and treated with various medications, including beta blockers, calcium channel blockers, and diuretics, but his blood pressure remained consistently elevated.

The clinical team discovered that Dana's impaired ability to break down homocysteine was due to a gene mutation specifically called MTRR. This gene codes for the enzymes that break down homocysteine and turn it into methionine. If this conversion is impaired, homocysteine levels can rise and cause hypertension.

It is essential to test for high levels of homocysteine and gene mutations such as MTRR in individuals with hypertension to determine the underlying cause and provide appropriate treatment.

Dana White's Case Study on JRE 2060

Dana White, the President of the Ultimate Fighting Championship (UFC), had a life-changing experience after taking a genetic test that looks at genetic methylation pathways. He was introduced to the test by a mutual friend named Carrie Kasm, who also had a life-changing experience after taking the same test.

The test looks at several genes that govern methylation, which is a process that refines raw materials in the body into usable forms. If a person has an impaired ability to make this conversion, it can lead to deficiencies and common ailments.

In Dana's case, he had one of the highest levels of homocysteine that the clinical team had ever seen. Homocysteine is an amino acid in the bloodstream that, when not broken down properly, can cause hyperhomocysteinemia. This condition can lead to hypertension or high blood pressure, which is a silent killer in cardiovascular disease.

Dana's blood pressure was consistently high, even though he was on medication such as beta blockers, calcium channel blockers, and diuretics. His blood pressure was around 160/110, which is considered very high.

The clinical team took his blood pressure two or three times a day, seven days a week. However, his blood pressure remained elevated. This led to the team testing for a gene mutation specifically called MTR or MTRR, which codes for the enzymes that break down homocysteine and turn it into a harmless amino acid called methionine.

Dana's case is a common one, as hypertension is often of unknown origin and caused by deficiencies rather than genetically inherited diseases. The test that Dana took helped him identify the root cause of his hypertension, allowing him to take necessary steps to improve his health.

Understanding Blood Pressure

Blood pressure is the force of blood pushing against the walls of the arteries as the heart pumps it throughout the body. It is measured in millimeters of mercury (mmHg) and consists of two numbers: systolic pressure (the top number) and diastolic pressure (the bottom number).

A normal blood pressure reading is around 120/80 mmHg. However, high blood pressure, also known as hypertension, is a common condition that affects many individuals. It is often referred to as the "silent killer" because it usually has no symptoms and can go undetected for years.

High blood pressure can lead to serious health problems such as heart attacks, strokes, and kidney failure. It is important to monitor and control blood pressure levels to prevent these complications.

One of the major causes of high blood pressure is the inability to refine a raw material, which causes a deficiency that leads to the disease. This process is called methylation and there are several genes that govern it. In fact, 85% of all high blood pressure cases are of unknown origin.

A genetic test that looks at methylation pathways can be used to identify deficiencies that may lead to high blood pressure. One amino acid in the bloodstream, homocysteine, has been linked to hypertension. High levels of homocysteine in the blood can cause vascular narrowing, leading to increased blood pressure.

While medications such as beta blockers, calcium channel blockers, ACE inhibitors, and diuretics can be used to control high blood pressure, it is important to address the underlying deficiencies that may be causing it. By identifying and addressing these deficiencies, individuals can better manage their blood pressure and prevent serious health complications.

The Silent Killer: High Blood Pressure

High blood pressure, also known as hypertension, is a common condition that affects a large number of people worldwide. It is often referred to as the "silent killer" because it can have no symptoms, yet can lead to serious health problems such as heart disease, stroke, and kidney failure.

One of the main causes of high blood pressure is an impaired ability to refine a raw material called homocysteine, which is an amino acid found in the bloodstream. When homocysteine levels rise due to an impaired ability to break it down and convert it into a harmless amino acid called methionine, it becomes one of the more inflammatory compounds in the human body. As it cruises by the inside lining of the artery, it starts to irritate the artery, reduces the artery's elasticity, and can even cause it to constrict. This narrowing can drive blood pressure up, leading to hypertension.

In fact, 85% of all hypertensive diagnoses are idiopathic, meaning of unknown origin. Only 15% of them are secondary hypertension, where the exact cause is known. Therefore, people with high blood pressure often undergo a battery of tests to determine the underlying cause, including an EKG, EEG, heart and lung sounds, and cardiovascular tests. However, even when all these tests come out normal, the person still has high blood pressure due to high levels of homocysteine.

In some cases, people have a gene mutation called MTR or MTRR, which codes for the enzymes that break down homocysteine and turn it into methionine. If this conversion is impaired, homocysteine levels rise, and the vascular system constricts, driving blood pressure up.

High blood pressure is a serious condition that should not be ignored. It is essential to monitor blood pressure regularly and seek medical attention if it is consistently high. Medications such as beta-blockers, calcium channel blockers, ACE inhibitors, and diuretics can help control blood pressure. However, lifestyle changes such as a healthy diet, regular exercise, and stress reduction can also be effective in managing high blood pressure.

Medical Interventions for Hypertension

Hypertension, commonly known as high blood pressure, affects a significant portion of the population. While 15% of high blood pressure cases have a known cause, the remaining 85% are of unknown origin, making them difficult to treat. Medical interventions for hypertension include beta blockers, calcium channel blockers, ACE inhibitors, and diuretics, among others. However, these medications may not always be effective in controlling blood pressure.

One potential underlying cause of hypertension is an impaired ability to break down an amino acid called homocysteine, which can lead to high levels of homocysteine in the blood. High homocysteine levels can cause vascular narrowing, leading to increased blood pressure. In some cases, a gene mutation called MTR or MTRR can impair the conversion of homocysteine into a harmless amino acid called methionine.

A genetic test that looks at methylation pathways can identify potential issues with homocysteine metabolism. By identifying and addressing underlying issues, medical interventions can be more effective in controlling blood pressure. It is important to note that lifestyle changes, such as diet and exercise, can also play a significant role in managing hypertension.